Bristol-Myers Squibb Company (BMY)'s 30-day implied volatility (IV30) was 31.1% at the close on November 2, 2026, down from 31.6% the day before, against a 52-week range of 19.5% to 41.2%. Its 20-day historical volatility was 33.6%.
Data as of November 2, 2026.